|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
ATE195022T1
(de)
|
1987-04-27 |
2000-08-15 |
Unilever Nv |
Spezifische bindungstestverfahren
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
EP0582368B1
(en)
|
1992-05-29 |
2001-01-24 |
Eli Lilly And Company Limited |
Thienobenzodiazepine derivatives for treatment of CNS disorders
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
ATE410514T1
(de)
|
1994-06-10 |
2008-10-15 |
Oklahoma Med Res Found |
Calciumbindende rekombinante antikörper gegen protein c
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
AU8148898A
(en)
|
1997-06-23 |
1999-01-04 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
US7193065B2
(en)
|
2001-07-13 |
2007-03-20 |
Roche Diagnostics Operations, Inc. |
Protease inhibitor conjugates and antibodies useful in immunoassay
|
|
WO2003072736A2
(en)
*
|
2002-02-21 |
2003-09-04 |
Duke University |
Reagents and treatment methods for autoimmune diseases
|
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
|
ATE380818T1
(de)
|
2002-03-28 |
2007-12-15 |
Lilly Co Eli |
Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
JP2005538108A
(ja)
*
|
2002-07-29 |
2005-12-15 |
ポトマック， ファーマ， エルエルシー |
α−２アドレナリン作動性レセプターアンタゴニストと非定型抗精神病薬精神安定薬との抗精神病薬組み合わせ治療および組成物
|
|
ES2285227T3
(es)
|
2002-08-05 |
2007-11-16 |
Eli Lilly And Company |
Arilbenzodiazepinas sustituidas con piperazina.
|
|
WO2005000901A2
(en)
|
2003-05-09 |
2005-01-06 |
Duke University |
Cd20-specific antibodies and methods of employing same
|
|
JP5144930B2
(ja)
|
2003-08-18 |
2013-02-13 |
ハー・ルンドベック・アクチエゼルスカベット |
トランス−１−（６−クロロ−３−フェニルインダン−１−イル）−３，３−ジメチルピペラジン
|
|
EP1664007B1
(en)
|
2003-09-23 |
2009-12-23 |
Fermion Oy |
Preparation of quetiapine
|
|
KR101255074B1
(ko)
|
2003-10-01 |
2013-04-16 |
아돌로 코포레이션 |
스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
|
|
KR100931784B1
(ko)
|
2003-10-23 |
2009-12-14 |
오츠카 세이야쿠 가부시키가이샤 |
방출조절성 멸균 아리피프라졸 주사제, 그 제조방법
|
|
AU2004298660B2
(en)
|
2003-12-12 |
2010-04-22 |
Abbott Rapid Diagnostics International Unlimited Company |
Assay
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
JP4943144B2
(ja)
*
|
2004-04-26 |
2012-05-30 |
松山 隆美 |
葉酸リセプターベータ（ＦＲ−β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
FR2878850B1
(fr)
|
2004-12-02 |
2008-10-31 |
Cis Bio Internat Sa |
Derives de l'inositol-1-phosphate
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
CN101636182B
(zh)
|
2006-10-25 |
2013-01-16 |
雷蒙特亚特特拉维夫大学有限公司 |
具有谷氨酸nmda活性的新型精神病治疗剂
|
|
US20080138842A1
(en)
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
|
ES2405364T3
(es)
|
2006-12-29 |
2013-05-30 |
Abbott Laboratories |
Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
|
|
CN101091700B
(zh)
|
2007-07-03 |
2011-06-08 |
上海现代药物制剂工程研究中心有限公司 |
富马酸喹硫平缓控释制剂组合物及其制备用途
|
|
MX2010003259A
(es)
|
2007-09-27 |
2010-04-12 |
Novartis Ag |
Ensayo de monitoreo de farmacos.
|
|
NZ590563A
(en)
|
2008-07-21 |
2012-06-29 |
Probiodrug Ag |
Diagnostic antibody assay
|
|
JP2011529923A
(ja)
|
2008-08-06 |
2011-12-15 |
ゴスフォース センター（ホールディングス）プロプライエタリー リミテッド |
精神障害（ｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒ）を治療するための組成物および方法
|
|
US20100069356A1
(en)
|
2008-09-17 |
2010-03-18 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
WO2010043893A1
(en)
|
2008-10-14 |
2010-04-22 |
Astrazeneca Ab |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
US20100144781A1
(en)
|
2008-10-29 |
2010-06-10 |
Dong-Jing Fu |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
US8480333B2
(en)
|
2008-12-26 |
2013-07-09 |
Steven Edward DeMay |
Frame rail assemblies and interlocking frame rail systems
|
|
NZ594071A
(en)
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
JP5986382B2
(ja)
|
2009-03-10 |
2016-09-06 |
ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ |
抗原提示細胞ターゲティング癌ワクチン
|
|
CA2785846C
(en)
|
2009-12-31 |
2015-07-07 |
Kempharm, Inc. |
Amino acid conjugates of quetiapine, process for making and using the same
|
|
SI2544536T1
(sl)
|
2010-03-11 |
2019-03-29 |
Kempharm, Inc. |
Maščobno kislinski konjugati kvetiapina proces za njih izdelavo in uporabo
|
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
WO2012003418A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine d2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
WO2013088255A1
(en)
|
2011-12-15 |
2013-06-20 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
MX2015002036A
(es)
|
2012-08-16 |
2016-01-22 |
Janssen Pharmaceutica Nv |
Pirazoles sustituidos como bloqueadores del canal de calcio tipo n.
|
|
ES2822914T3
(es)
|
2012-08-21 |
2021-05-05 |
Janssen Pharmaceutica Nv |
Haptenos de aripiprazol y su uso en inmunoensayos
|
|
CA2882557C
(en)
|
2012-08-21 |
2020-10-27 |
Ortho-Clinical Diagnostics, Inc. |
Haptens of quetiapine for use in immunoassays
|
|
CN104755093B
(zh)
|
2012-08-21 |
2018-11-16 |
詹森药业有限公司 |
奥氮平半抗原的抗体及其用途
|
|
TR201816416T4
(tr)
|
2012-08-21 |
2018-11-21 |
Janssen Pharmaceutica Nv |
Risperidona yönelik antikorlar ve bunların kullanımı.
|
|
ES2762105T3
(es)
|
2012-08-21 |
2020-05-22 |
Janssen Pharmaceutica Nv |
Anticuerpos para aripiprazol y uso de los mismos
|
|
TR201809424T4
(tr)
|
2012-08-21 |
2018-07-23 |
Janssen Pharmaceutica Nv |
Risperidon ve paliperidon haptenleri.
|
|
AU2013305965B2
(en)
|
2012-08-21 |
2017-08-24 |
Saladax Biomedical Inc. |
Antibodies to paliperidone and use thereof
|
|
WO2014031668A2
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc |
Antibodies to quetiapine and use thereof
|
|
CN104755928B
(zh)
|
2012-08-21 |
2017-05-10 |
詹森药业有限公司 |
奥氮平的抗体及其用途
|
|
CA2882489A1
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to paliperidone haptens and use thereof
|
|
ES2978909T3
(es)
|
2012-08-21 |
2024-09-23 |
Janssen Pharmaceutica Nv |
Anticuerpos contra haptenos de aripiprazol y uso de los mismos
|
|
EP3492473B1
(en)
|
2012-08-21 |
2025-07-30 |
Janssen Pharmaceutica NV |
Haptens of olanzapine
|
|
PT3663317T
(pt)
|
2012-08-21 |
2023-01-23 |
Janssen Pharmaceutica Nv |
Anticorpos para haptenos de quetiapina e sua utilização
|
|
JP6374387B2
(ja)
|
2012-08-21 |
2018-08-15 |
ヤンセン ファーマシューティカ エヌ．ベー． |
リスペリドンハプテンへの抗体及びその使用
|
|
EP3556759B1
(en)
|
2012-08-21 |
2023-11-29 |
Janssen Pharmaceutica NV |
Haptens of paliperidone
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
|
AU2016370853A1
(en)
|
2015-12-17 |
2018-06-07 |
Saladax Biomedical Inc. |
Antibodies to quetiapine and use thereof
|